LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 18.98 | 27.76 | 1063 | 941 | 1.1295 | 1.0485 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 20.68 | 27.76 | 1 | 1119 | 0.0009 | -0.4638 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 20.68 | 27.76 | 1018 | 1119 | 0.9097 | 0.9648 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 20.68 | 27.76 | 38 | 1119 | 0.0340 | 0.0607 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 20.68 | 27.76 | 1108 | 1119 | 0.9902 | 0.9963 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 22.39 | 27.76 | 2 | 1305 | 0.0015 | -0.3772 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 22.39 | 27.76 | 1111 | 1305 | 0.8509 | 0.9427 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 22.39 | 27.76 | 59 | 1305 | 0.0452 | 0.1454 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 22.39 | 27.76 | 1201 | 1305 | 0.9198 | 0.9701 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.09 | 27.76 | 2 | 1461 | 0.0014 | -0.3687 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.09 | 27.76 | 1078 | 1461 | 0.7375 | 0.8963 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.09 | 27.76 | 69 | 1461 | 0.0472 | 0.1726 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.09 | 27.76 | 1153 | 1461 | 0.7888 | 0.9187 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 25.79 | 27.76 | 2 | 1605 | 0.0012 | -0.3620 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 25.79 | 27.76 | 1055 | 1605 | 0.6573 | 0.8616 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 25.79 | 27.76 | 69 | 1605 | 0.0430 | 0.1683 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 25.79 | 27.76 | 1067 | 1605 | 0.6647 | 0.8652 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 27.49 | 27.76 | 2 | 1723 | 0.0012 | -0.3570 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 27.49 | 27.76 | 1184 | 1723 | 0.6871 | 0.8779 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 27.49 | 27.76 | 94 | 1723 | 0.0546 | 0.2273 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 27.49 | 27.76 | 1184 | 1723 | 0.6871 | 0.8779 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 29.19 | 27.76 | 4 | 1863 | 0.0021 | -0.2733 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 29.19 | 27.76 | 1370 | 1863 | 0.7353 | 0.9012 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 29.19 | 27.76 | 140 | 1863 | 0.0751 | 0.3056 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 29.19 | 27.76 | 1294 | 1863 | 0.6945 | 0.8834 | MN20160318_Q01 | K13 |